apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Certican 0.25 Tablet

  3. Certican 0.25 Tablet Substitute

Certican 0.25 Tablet Substitute

Medicine Composition:

EVEROLIMUS-0.25MG

All Substitutes & Brand Comparisons

call Doctor

When Should You Consider Switching from Certican 0.25 Tablet ?

Patients may explore substitutes in the following scenarios:

  • High monthly cost of Certican 0.25 Tablet
  • Non-availability in local pharmacies
  • Generic recommendation by a doctor
  • Side effects or better tolerability with alternatives

What to Know Before Switching

Before you switch from Certican 0.25 Tablet to another medicine, here are some important points to keep in mind:

bannner image

Same salt, different brands:

Most substitutes contain the same active ingredient - EVEROLIMUS-0.25MG, but the fillers, coating, or manufacturing quality may vary slightly.

bannner image

Consult your doctor first:

Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.

bannner image

Watch out for allergies or reactions:

Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.

bannner image

Price ≠ effectiveness:

A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.

bannner image

Check the dosage form and strength:

Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.

Uses

Certican 0.25 Tablet is used in the treatment of Breast cancer, pancreatic cancer, lung cancer, and kidney cancer. The detailed uses of Certican 0.25 Tablet are as follows:

  • Cancer Treatment: Certican 0.25 Tablet is used for various cancers, including advanced hormone receptor-positive breast cancer, pancreatic neuroendocrine tumors, and neuroendocrine tumors of the stomach, lungs, and intestines that cannot be treated surgically.
  • Kidney Cancer Management: Certican 0.25 Tablet is used in advanced renal cell carcinoma when other treatments have failed.
  • Organ Transplant Rejection Prevention: Certican 0.25 Tablet helps prevent rejection in kidney and liver transplant patients by suppressing the immune system.
  • Tuberous Sclerosis Complex (TSC)-Related Tumors: Certican 0.25 Tablet is indicated for treating certain benign tumors associated with TSC, such as subependymal giant cell astrocytoma (SEGA) and renal angiomyolipoma.
  • Immunosuppressive Therapy: As an mTOR inhibitor, Certican 0.25 Tablet reduces the activity of immune cells, helping manage autoimmune conditions and prevent transplant-related complications.

Medicinal Benefits

Certican 0.25 Tablet is indicated to the patients dealing with breast cancer, pancreatic cancer, lung cancer, kidney cancer and stomach/ intestinal cancer. Cancer of this type tends to spread quickly in other parts of the body. Certican 0.25 Tablet travels through the bloodstream and effectively destroys cancerous cells and other parts of the body. It works by decreases the activity of the immune system of the body and prevents rejection of the transplanted organ. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells. Besides this, it is also effective in people with genetic disorders to treat some types of tumors in the brain or kidney.

FAQs

The substitutes of Certican 0.25 Tablet contain the same active salt(s) - EVEROLIMUS-0.25MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.

Switching to a generic substitute medicine in the place of Certican 0.25 Tablet is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.

Generics versions of Certican 0.25 Tablet are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.

Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.

Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.

Substitutes of Certican 0.25 Tablet meet the same safety and efficacy standards as Certican 0.25 Tablet , but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.

Yes. Substitutes of Certican 0.25 Tablet may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.

Yes, it’s generally safe to switch between multiple substitutes of Certican 0.25 Tablet if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.

Yes, many people safely use substitutes of Certican 0.25 Tablet for long-term treatment. Just ensure it’s done under medical supervision.

If your symptoms stay under control or lab results remain stable, the substitute for Certican 0.25 Tablet is likely working well. Regular follow-ups with your doctor are important.

Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Certican 0.25 Tablet to its substitute. Always consult your doctor before switching.

Certican 0.25 Tablet is used to treat breast cancer, pancreatic cancer, lung cancer and kidney cancer.

Certican 0.25 Tablet is an anticancer medicine. It belongs to a group of medicines known as a kinase inhibitor. It works by lowering the blood supply to the tumor, which reduces the growth and spread of cancer cells.

There is no specific duration of treatment with Certican 0.25 Tablet . Certican 0.25 Tablet is continued till benefit is seen or undesirable toxicity or side effects occur.

You should prevent grapefruit or grapefruit juice while taking Certican 0.25 Tablet . This is because taking them together may rise the levels of Certican 0.25 Tablet in your blood to toxic levels. Avoid the use of live vaccinations and any probable contact with people who have received live vaccinations.

Certican 0.25 Tablet can lead to serious side effects that consist of severe allergic reactions, angioedema (painless swelling under the skin) and kidney failure which can be dangerous and can lead to death. It is possible that you may develop an infection or problems associated to lungs like breathing problems.

It usually takes three to six months for most types of lung cancer to double their size. It will take a long time for lung cancer to reach a size that could be diagnosed in X-Ray.

Certican 0.25 Tablet contains Everolimus, which belongs to the group of medicines known as kinase inhibitors.

Regular monitoring is essential when using Certican 0.25 Tablet . Your doctor may check your blood tests, blood sugar, blood pressure, and kidney function. They may also adjust your dose based on your response to treatment or any side effects that occur. It's essential to report any changes or concerns to your doctor to ensure safe and effective treatment.

While taking Certican 0.25 Tablet , avoiding certain things is essential to ensure your safety. Avoid consuming grapefruit juice and products and St. John's Wort, as they can interact with the medication. Certain antibiotics, antifungals, and medications can also interact with Everolimus, so consult your doctor before taking any new medications. Additionally, consult your doctor before receiving any vaccinations and avoid high-risk activities that may increase the risk of infections and bleeding. It's also important to avoid getting pregnant or fathering a child while taking Everolimus, as well as breastfeeding. Finally, limit your sun exposure to avoid increasing the risk of skin cancer. Always consult your doctor or pharmacist for a comprehensive list of medications and activities to avoid while taking Everolimus.

Before using any medication, including Certican 0.25 Tablet , you should know its purpose, usage, safety profile, precautions, and limitations.

Certican 0.25 Tablet is administered orally in the form of a tablet. Take Everolimus with or without food, as advised by your doctor. Swallow the tablet whole with water; do not crush, break, or chew it. Note: It's important to follow your doctor's instructions and take Certican 0.25 Tablet exactly as prescribed

By regularly monitoring your progress through brain scans and other evaluations, your doctor can determine if Certican 0.25 Tablet is effectively shrinking your brain tumor.

Certican 0.25 Tablet is indeed considered a cytotoxic medication, but it's a targeted therapy that specifically targets cancer cells and inhibits their growth. It's not a traditional chemotherapy medication, but it can still have side effects and be harmful to healthy cells to some extent. If you have any concerns or questions, please consult your doctor or healthcare team to discuss potential risks and benefits and manage any side effects.

Common side effects of Certican 0.25 Tablet may include weakness, infection, sinus inflammation, cough, diarrhoea, fever, fatigue, otitis media (infection of the ear), stomatitis (Inflammation of the mouth) and upper respiratory tract infection. Most of these side effects of Certican 0.25 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Apollo 247 Floating Button

Buy best Immuno Suppressants products by